share_log

藥明巨諾-B：致非登記股東之信函及回條 - 以電子方式發布公司通訊之安排

JW THERAP-B: Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

香港交易所 ·  Jan 19 03:35
Summary by Moomoo AI
药明巨诺-B（開曼）有限公司於2024年1月19日宣布，根據香港聯合交易所有限公司證券上市規則第2.07條，公司將從2023年12月31日起採用電子方式發布公司通訊，包括董事報告、財務報告等。公司通知非登記股東，所有公司通訊的英文和中文版本將在公司網站及披露易網站上提供，取代印刷本。非登記股東需向持股的中介公司提供有效電郵地址以收取通訊，否則將以印刷本形式發送。股東如需印刷版通訊，可填妥回條並聯絡股份過戶處。
药明巨诺-B（開曼）有限公司於2024年1月19日宣布，根據香港聯合交易所有限公司證券上市規則第2.07條，公司將從2023年12月31日起採用電子方式發布公司通訊，包括董事報告、財務報告等。公司通知非登記股東，所有公司通訊的英文和中文版本將在公司網站及披露易網站上提供，取代印刷本。非登記股東需向持股的中介公司提供有效電郵地址以收取通訊，否則將以印刷本形式發送。股東如需印刷版通訊，可填妥回條並聯絡股份過戶處。
Pharmaceutical Ming Juneo-B (Cayman) Limited announced on 19 January 2024 that, pursuant to Article 2.07 of the Securities Listing Rules of the Hong Kong Stock Exchange Limited, the Company will publish corporate communications electronically from 31 December 2023, including directors' reports, financial reports, etc. The Company informs non-registered shareholders that the English and Chinese versions of all company communications will be available on the Company's website and on the Disclosable Website, in place of the printed copies. Non-registered shareholders are required to provide a valid email address to the holding intermediary company to receive the communication, otherwise it will be sent in printed form. Shareholders may complete the return form and contact the Share Receipt Office if they require printed communications.
Pharmaceutical Ming Juneo-B (Cayman) Limited announced on 19 January 2024 that, pursuant to Article 2.07 of the Securities Listing Rules of the Hong Kong Stock Exchange Limited, the Company will publish corporate communications electronically from 31 December 2023, including directors' reports, financial reports, etc. The Company informs non-registered shareholders that the English and Chinese versions of all company communications will be available on the Company's website and on the Disclosable Website, in place of the printed copies. Non-registered shareholders are required to provide a valid email address to the holding intermediary company to receive the communication, otherwise it will be sent in printed form. Shareholders may complete the return form and contact the Share Receipt Office if they require printed communications.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more